Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.

about

A comparative study of Sr-incorporated mesoporous bioactive glass scaffolds for regeneration of osteopenic bone defects.A comparative study of strontium-substituted hydroxyapatite coating on implant's osseointegration for osteopenic rats.

P2860

Q39196610-349B18C0-F399-4BC2-839A-B06D576768C4 Q50906643-67925856-CA8D-4D98-A34E-4AC7A7203A29

P2860

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.

Item

http://www.wikidata.org/entity/Q36997684

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.

@en

type

Item

label

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.

@en

prefLabel

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.

@en

P1476

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.

@en

P2093

J-Y Reginster

http://www.w3.org/2001/XMLSchema#string

M Hiligsmann

http://www.w3.org/2001/XMLSchema#string

O Bruyère

http://www.w3.org/2001/XMLSchema#string

W Ben Sedrine

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden.

Updated data on proximal femur bone mineral levels of US adults.

The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study.

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.

Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.

Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate.

Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.

P2888

s00198-013-2272-2

P304

2291-2300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00198-013-2272-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235392110

http://www.w3.org/2001/XMLSchema#string

P698

23371359

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

P932

3706715

http://www.w3.org/2001/XMLSchema#string

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.

about

P2860

P2860

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932